BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12075110)

  • 1. Effects of phenobarbital on DNA methylation in GC-rich regions of hepatic DNA from mice that exhibit different levels of susceptibility to liver tumorigenesis.
    Watson RE; Goodman JI
    Toxicol Sci; 2002 Jul; 68(1):51-8. PubMed ID: 12075110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 mice.
    Bachman AN; Phillips JM; Goodman JI
    Toxicol Sci; 2006 Jun; 91(2):393-405. PubMed ID: 16537655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation and global methylation status changes in mouse liver after phenobarbital and/or choline-devoid, methionine-deficient diet administration.
    Counts JL; Sarmiento JI; Harbison ML; Downing JC; McClain RM; Goodman JL
    Carcinogenesis; 1996 Jun; 17(6):1251-7. PubMed ID: 8681439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesis.
    Phillips JM; Yamamoto Y; Negishi M; Maronpot RR; Goodman JI
    Toxicol Sci; 2007 Mar; 96(1):72-82. PubMed ID: 17172636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diethanolamine and phenobarbital produce an altered pattern of methylation in GC-rich regions of DNA in B6C3F1 mouse hepatocytes similar to that resulting from choline deficiency.
    Bachman AN; Kamendulis LM; Goodman JI
    Toxicol Sci; 2006 Apr; 90(2):317-25. PubMed ID: 16396840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.
    Phillips JM; Goodman JI
    Toxicol Sci; 2009 Apr; 108(2):273-89. PubMed ID: 19233941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genes that may play critical roles in phenobarbital (PB)-induced liver tumorigenesis due to altered DNA methylation.
    Phillips JM; Goodman JI
    Toxicol Sci; 2008 Jul; 104(1):86-99. PubMed ID: 18359763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of DNA: a possible epigenetic mechanism involved in tumor promotion.
    Counts JL; Goodman JI
    Prog Clin Biol Res; 1995; 391():81-101. PubMed ID: 8532739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    Toxicol Appl Pharmacol; 1989 Sep; 100(3):398-410. PubMed ID: 2551075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
    Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
    Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors.
    Ray JS; Harbison ML; McClain RM; Goodman JI
    Mol Carcinog; 1994 Mar; 9(3):155-66. PubMed ID: 7908202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice.
    Diwan BA; Rice JM; Ohshima M; Ward JM
    Carcinogenesis; 1986 Feb; 7(2):215-20. PubMed ID: 3948311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain differences in hepatic tumor promotion by phenobarbital in diethylnitrosamine- and dimethylnitrosamine-initiated infant male mice.
    Weghorst CM; Pereira MA; Klaunig JE
    Carcinogenesis; 1989 Aug; 10(8):1409-12. PubMed ID: 2752514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effect of tumor promoter treatments on DNA methylation status and gene expression in B6C3F1 and C57BL/6 mouse liver and in B6C3F1 mouse liver tumors.
    Counts JL; McClain RM; Goodman JI
    Mol Carcinog; 1997 Feb; 18(2):97-106. PubMed ID: 9049185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the methylation status of the 5' flanking region of Ha-ras in B6C3F1, C3H/He and C57BL/6 mouse liver.
    Counts JL; Goodman JI
    Cancer Lett; 1993 Dec; 75(2):129-36. PubMed ID: 8293423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phenobarbital-induced hypermethylation of the p53 promoter region in the liver of Wistar rats].
    Kostka G; Urbanek-Olejnik K; Wiadrowska B; BaƄkowski R
    Rocz Panstw Zakl Hig; 2008; 59(4):455-65. PubMed ID: 19227257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenobarbital elicits unique, early changes in the expression of hepatic genes that affect critical pathways in tumor-prone B6C3F1 mice.
    Phillips JM; Burgoon LD; Goodman JI
    Toxicol Sci; 2009 Jun; 109(2):193-205. PubMed ID: 19270015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of phenobarbital on the methylation level of the p16 promoter region in rat liver.
    Kostka G; Urbanek K; Ludwicki JK
    Toxicology; 2007 Sep; 239(1-2):127-35. PubMed ID: 17706854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in methyl-sensitive restriction sites of liver DNA from hamsters chronically exposed to hydrazine sulfate.
    Zheng H; Shank RC
    Carcinogenesis; 1996 Dec; 17(12):2711-7. PubMed ID: 9006110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital.
    Gonzales AJ; Christensen JG; Preston RJ; Goldsworthy TL; Tlsty TD; Fox TR
    Carcinogenesis; 1998 Jul; 19(7):1173-83. PubMed ID: 9683175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.